Terry-Ann Burrell, Chief Financial Officer at Beam Therapeutics Inc. (BEAM), sold 94,390 shares at $45.14 ($4.3M) on 2023-01-18, disclosed to the SEC on 2023-01-20.
Open-market sale of $4.3M BEAM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.14 | 47,195 | $2.1M | 50.0% |
| 2 | $45.14 | 47,195 | $2.1M | 50.0% |
| Total | $45.14 avg | 94,390 | $4.3M | 100% |
| Filing → |
| BEAM | SELL | 2023-04-05 | $276K | — | Filing → |
| BEAM | SELL | 2023-01-30 | $3.3M | — | Filing → |
| BEAM | SELL | 2023-01-25 | $1.8M | — | Filing → |